Absolute Antibody

Absolute Antibody was founded in 2012 with a vision to make recombinant antibody technology accessible to all. We offer antibody sequencing, engineering and recombinant production as royalty-free custom services, as well as a unique reagents catalog of recombinant antibodies and Fc Fusion proteins, engineered into new and useful formats. Our customers include leading pharmaceutical, biotechnology and diagnostics companies, as well as academic researchers worldwide. Our international customer base is served by our ISO 9001:2015-certified antibody manufacturing facility in Northeast England and additional offices in Boston in the United States and Amsterdam in the Netherlands. In 2022, we became part of...

Antibody expression and purification,hybridoma sequencing,antibody engineering,transient mammalian expression,antibody humanization,recombinant antibodies,and bispecific antibodies

Absolute antibody operates in the Biotechnology research industry.

Absolute antibody's revenue is 11m - 100m

Absolute antibody has 11 - 50 employees.